Medtronic trial meets primary endpoints for Hugo™ robotic-assisted surgery system

 Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting

 
Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration

https://news.medtronic.com/2025-04-26-Medtronic-Expand-URO-U-S-clinical-trial-meets-safety-and-effectiveness-primary-endpoints-for-Hugo-TM-robotic-assisted-surgery-system